Experiment 130488

Worktypes

STRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEPHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

SPIROSTAN-3-BETA-OL,5-ALPHA: 4-O-(2-O-(3-O-(ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSYL)-3-O-(4-O-(ALPHA-L-RHAMNOPYRANOSYL)-BETA-D-GLUCOPYRANOSYL)-BETA-D-GLUCOPYRANOSYL)-BETA-D-GALACTOPYRANOSIDE

Details

PropertyValue
Pharmacology
CYCLIC AMP PHOSPHODIESTERASE INHIBITION
OrganismCamassia cusickii (LILIACEAE)
CitationMAMAKI,Y: SAASHIDA,Y: NAKAIDO,T: OHMOTO,T:. (1992). TIGOGENIN HEXASACCHARIDES FROM CAMASSIA CUSICKII. STRUCTURAL ELUCIDATION BY MODERN NMR TECHNIQUES.. 65(2)
Amount utilized
Compound isolated
Dose amount132.0 MICROMOLS
Number2
Qualitative resultACTIVE
Dose expressionIC50